The 80th Annual Meeting of the Japanese Society of Hematology

Session information

Oral Session

Oral Session 2-11C Novel therapies for ALL

Sat. Oct 13, 2018 2:50 PM - 3:50 PM No.11 (Osaka International Convention Center, 10F 1004-5)

Chair: Kiyotoshi Imai (Miyanomori Hospital, Japan)

Koji Sasaki1, Hagop Kantarjian1, Farhad Ravandi1, Naval Daver1, Tapan Kadia1, Rita Beatrice Khouri1, Alvarado Yesid1, Jan Burger1, Deborah Thomas1, Guillermo Garcia-Manero1, Courtney Dinardo1, Naveen Pemmaraju1, Nicholas Short1, Heather Schroeder1, Rebecca Garris1, Prithviraj Bose1, Nitin Jain1, Kiran Naqvi1, William Wierda1, Srdan Verstovsek1, Jorge Cortes1, Marina Konopleva1, Susan Obrien2, Elias Jabbour1 (1.MD Anderson Cancer Center, Houston, TX, U.S.A., 2.The University of California, Irvine, U.S.A.)

Masayuki Hino1, Toshiki Uchida2, Yasushi Onishi3, Chul Won Jung4, Yeow Tee Goh5, Kiyoshi Ando6, Ming Chung Wang7, Chiho Ono8, Miyako Matsumizu8, M. Luisa Paccagnella9, Barbara Sleight9, Erik Vandendries10, Yosuke Fujii8, Naohito Fujishima11 (1.Hematology, Osaka City University, Osaka, Japan, 2.Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan, 3.Tohoku University Hospital, Sendai, Japan, 4.Samsung Medical Center, Seoul, South Korea, 5.Singapore General Hospital, Bukit Merah, Singapore, 6.Tokai University Hospital, Isehara, Japan, 7.Chang Gung Medical Foundation, Taipei, Taiwan, 8.Pfizer Japan Inc, 9.Pfizer Inc, Groton, CT, USA, 10.Pfizer Inc, Cambridge, MA, USA, 11.Akita University, Akita, Japan)

Hidefumi Hiramatsu1, Lamis Eldjerou2, Kathryn Lund2, Kota Tokushige3, Yoko Watanabe3, Stephan A. Grupp4,5 (1.Dept. of Pediatrics, Kyoto Univ., Kyoto, Japan, 2.Novartis Pharmaceuticals Co., New Jersey, USA, 3.Novartis Pharma KK, Tokyo, Japan, 4.Children's Hospital of Philadelphia, Pennsylvania, USA, 5.Perelman School of Medicine, Univ. of Pennsylvania, Pennsylvania, USA)